Difficult Disease Diagnosis Delivered
David Seftel, MD, MBA
Wednesday, March 13, 2019
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Empowering early disease diagnosis for timely personalized treatment
About Me
Jesse Cortez
How do we know?
What does Enable Do?
Difficult Diseases Defined
The Difficult Disease Pains
All of these problems have a common origin
A snapshot
Late Diagnosis of Antibody-Biomarker-Associated Diseases
ADAP: Antibody Detection by Agglutination-PCR
The Solution to In-Time Diagnosis: Exactly How Sensitive is ADAP
ADAP performance has been validated across three traditionally
Enable’s products: Addressing unmet clinical and therapeutic needs across the entire patient flow
While Genomics reveals a still snapshot
Current IP and Peer Recognition Record
Team
The Challenge
Antibody Detection by Agglutination-qPCR (ADAP)
Performance
ADAP process without automation
The Solution
The Solution cont.
Why Hamilton
Performance
ADAP process with automation
IASP Results
IASP Results cont.
IASP Results cont.
ADAP/RIA comparison matrix
Customers / Collaborators
Our Pipeline : Other Difficult Diseases
Why offer an Enable – Hamilton Solution?
Product and Service Availability
Summary
Let us help you win!
Special Thanks to the Incredible Hamilton Team
Enable Biosciences
Thank you
No transcript for this webinar
More Information
Request Info
Contact Dr. Seftel